...
首页> 外文期刊>Cell death & disease. >KIF4A facilitates cell proliferation via induction of p21-mediated cell cycle progression and promotes metastasis in colorectal cancer
【24h】

KIF4A facilitates cell proliferation via induction of p21-mediated cell cycle progression and promotes metastasis in colorectal cancer

机译:KIF4A通过诱导p21介导的细胞周期进程促进细胞增殖,并促进结直肠癌的转移

获取原文
           

摘要

Kinesin family member 4A (KIF4A) was found to be implicated in the regulation of chromosome condensation and segregation during mitotic cell division, which is essential for eukaryotic cell proliferation. However, little is known about the role of KIF4A in colorectal carcinoma (CRC). This study explored the biological function of KIF4A in CRC progression and investigated the potential molecular mechanisms involved. Here, we found that KIF4A was remarkably upregulated in primary CRC tissues and cell lines compared with paired non-cancerous tissues and normal colorectal epithelium. Elevated expression of KIF4A in CRC tissues was significantly correlated with clinicopathological characteristics in patients as well as with shorter overall and disease-free cumulative survival. Multivariate Cox regression analysis revealed that KIF4A was an independent prognostic factor for poor survival in human CRC patients. Functional assays, including a CCK-8 cell proliferation assay, colony formation analysis, cancer xenografts in nude mice, cell cycle and apoptosis analysis, indicated that KIF4A obviously enhanced cell proliferation by promoting cell cycle progression in vitro and in vivo. Furthermore, gene set enrichment analysis, Luciferase reporter assays, and ChIP assays revealed that KIF4A facilitates cell proliferation via regulating the p21 promoter, whereas KIF4A had no effect on cell apoptosis. In addition, Transwell analysis indicated that KIF4A promotes migration and invasion in CRC. Taken together, these findings not only demonstrate that KIF4A contributes to CRC proliferation via modulation of p21-mediated cell cycle progression but also suggest the potential value of KIF4A as a clinical prognostic marker and target for molecular treatments.
机译:发现驱动蛋白家族成员4A(KIF4A)参与有丝分裂细胞分裂过程中染色体浓缩和分离的调控,这对于真核细胞增殖至关重要。然而,关于KIF4A在大肠癌(CRC)中的作用知之甚少。这项研究探讨了KIF4A在CRC进展中的生物学功能,并研究了其中涉及的潜在分子机制。在这里,我们发现与配对的非癌组织和正常结直肠上皮相比,KIF4A在原发性CRC组织和细胞系中显着上调。 CRC组织中KIF4A的表达升高与患者的临床病理特征以及较短的总体和无病累积生存率显着相关。多变量Cox回归分析显示,KIF4A是人CRC患者生存不良的独立预后因素。功能测定,包括CCK-8细胞增殖测定,集落形成分析,裸鼠体内的异种移植,细胞周期和凋亡分析,表明KIF4A通过促进体外和体内细胞周期进程而明显增强了细胞增殖。此外,基因集富集分析,荧光素酶报告基因分析和ChIP分析表明,KIF4A通过调节p21启动子促进细胞增殖,而KIF4A对细胞凋亡没有影响。另外,Transwell分析表明,KIF4A促进CRC中的迁移和侵袭。综上所述,这些发现不仅表明KIF4A通过调节p21介导的细胞周期进程促进CRC增殖,还表明KIF4A作为临床预后标志物和分子治疗靶标的潜在价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号